DE3687995T2 - Verfahren zur reinigung von interferon und so hergestellte zusammensetzung. - Google Patents

Verfahren zur reinigung von interferon und so hergestellte zusammensetzung.

Info

Publication number
DE3687995T2
DE3687995T2 DE8686302960T DE3687995T DE3687995T2 DE 3687995 T2 DE3687995 T2 DE 3687995T2 DE 8686302960 T DE8686302960 T DE 8686302960T DE 3687995 T DE3687995 T DE 3687995T DE 3687995 T2 DE3687995 T2 DE 3687995T2
Authority
DE
Germany
Prior art keywords
interferon
results
human immune
composition made
purifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE8686302960T
Other languages
English (en)
Other versions
DE3687995D1 (de
Inventor
Tsutomu Arakawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24921509&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3687995(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of DE3687995D1 publication Critical patent/DE3687995D1/de
Application granted granted Critical
Publication of DE3687995T2 publication Critical patent/DE3687995T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8686302960T 1985-04-25 1986-04-18 Verfahren zur reinigung von interferon und so hergestellte zusammensetzung. Revoked DE3687995T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/727,147 US4873312A (en) 1985-04-25 1985-04-25 Method for purifying interferon and composition of matter produced thereby

Publications (2)

Publication Number Publication Date
DE3687995D1 DE3687995D1 (de) 1993-04-22
DE3687995T2 true DE3687995T2 (de) 1993-06-24

Family

ID=24921509

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686302960T Revoked DE3687995T2 (de) 1985-04-25 1986-04-18 Verfahren zur reinigung von interferon und so hergestellte zusammensetzung.

Country Status (8)

Country Link
US (1) US4873312A (de)
EP (1) EP0199568B1 (de)
JP (1) JPH0733397B2 (de)
AT (1) ATE86868T1 (de)
CA (1) CA1263842A (de)
DE (1) DE3687995T2 (de)
IL (1) IL78455A (de)
WO (1) WO1986006385A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339757C (en) 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
US4931543A (en) * 1987-05-11 1990-06-05 Cetus Corporation Process for recovering microbially produced interleukin-2
US5599690A (en) * 1988-02-01 1997-02-04 Amgen Inc. Control of norleucine incorporation into recombinant proteins
US5391713A (en) * 1989-06-20 1995-02-21 Bionative Ab Interferon purification process
DE3926103A1 (de) * 1989-08-08 1991-02-14 Hoechst Ag Verfahren zur biokatalytischen korrekten kettenfaltung denaturierter rekombinanter fusionsproteine
DK580789D0 (da) * 1989-11-20 1989-11-20 Novo Nordisk As Fremgangsmaade til oprensning af polypeptider
US5986070A (en) * 1990-04-06 1999-11-16 Amgen Inc. Production of biologically active NGF proteins
IT1246296B (it) * 1990-07-25 1994-11-17 Sclavo Spa Procedimento di estrzione e purificazione del gamma interferone umano ricombinante

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
WO1984002129A1 (en) * 1982-11-22 1984-06-07 Takeda Chemical Industries Ltd Human immune interferon protein and process for its preparation
US4518526A (en) * 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
JPH06102034B2 (ja) * 1983-03-25 1994-12-14 セルテク リミテツド タンパク質の生産方法
US4476049A (en) * 1983-09-20 1984-10-09 Hoffmann-La Roche Inc. Method for the extraction of immune interferon
JPS6079000A (ja) * 1983-10-04 1985-05-04 Takeda Chem Ind Ltd ヒトγ型インタ−フエロン単量体の製造法
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor

Also Published As

Publication number Publication date
ATE86868T1 (de) 1993-04-15
DE3687995D1 (de) 1993-04-22
US4873312A (en) 1989-10-10
EP0199568A3 (en) 1988-09-21
JPS62502540A (ja) 1987-10-01
IL78455A (en) 1991-11-21
WO1986006385A1 (en) 1986-11-06
EP0199568B1 (de) 1993-03-17
IL78455A0 (en) 1986-08-31
EP0199568A2 (de) 1986-10-29
CA1263842A (en) 1989-12-12
JPH0733397B2 (ja) 1995-04-12

Similar Documents

Publication Publication Date Title
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
EP0132732A3 (en) Homologues from aprotinine whose lys 15 amino acid is substituted by other amino acids, process for their preparation and their use as medicaments
ATE56729T1 (de) Protein mit zellwachstumsstimulierender wirkung, dessen zusammensetzung und verfahren zu seiner herstellung.
ATE234108T1 (de) Therapeutikum zur unterdrückung von schnarchgeräuschen
DE3688663T2 (de) Reinigung und Aktivierung von Proteinen aus unlöslichen Einschlussteilchen.
ES8501979A1 (es) Procedimiento para preparar un concentrado de factor antihemofilico
ATE63823T1 (de) Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha.
ATE44236T1 (de) Verfahren zur herstellung eines hochgereinigten antihaemophilfaktor-konzentrats.
DE3687995D1 (de) Verfahren zur reinigung von interferon und so hergestellte zusammensetzung.
DE3686954D1 (de) Loeslichkeits-, reinigungs- und charakterisierungsverfahren fuer proteine aus unloeslichen proteinaggregaten oder proteinkomplexen und diesbezuegliche praeparate.
PT85053A (de) Peptide mit einfluss auf die diurese und natriurese verfahren zu ihrer herstellung diese enthaltende mittel und ihre verwendung
FI93842B (fi) Menetelmä proteiinien renaturoimiseksi
UA13377A (uk) Спосіб одержаhhя противірусhого засобу
FI93843C (fi) Menetelmä angiogeenisen tekijän tuottamiseksi
ATE44750T1 (de) Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats.
Yu et al. Purification and properties of cytochrome b from photosynthetic bacterium Rhodopseudomonas sphaeroides R-26
AT391482B (de) Verfahren zur industriellen herstellung von hochreinem menschlichem leukozyteninterferon
KR850005456A (ko) 고농도 단백질의 제조방법
JPS5625114A (en) Preparation of human gamma globulin
ATE86499T1 (de) Vorbeugende massnahmen zur verhinderung der ''komplexen respiratorischen erkrankung bei rindern'' durch verabreichung von interferon.
SU1412060A1 (ru) Способ выделения миоглобина из сердечной мышцы
RU93005154A (ru) Белки, фармацевтические композиции, нуклеиновые кислоты, векторы, системы вектор-хозяин, способ получения белка, способы модифицирования функции, способы лечения, способ трансфекции, способ переноса гена, способ измерения активности

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation